1.1. DREAM Challenge. The cross validation results for DREAM Challenge are presented in Table 2 . We also investigated SomaticSeq's accuracy in challenging regions (e.g., regions of low mappability, low complexity, etc). DREAM Challenge simulated only 25 mutations in regions ENCODE considered to be unmappable (in the wgEncodeDacMapabilityConsensusExcludable.bed file from UCSC). 24 out of those 25 mutations were captured by the combined five callers, and a total of 2,939 false positives were called. Thus, before any filtering, the union of 5 call sets had a F 1 score of 1.61% (recall of 96.0% and precision of 0.81%). After 10 cross-validations by SomaticSeq, the F 1 scores for DREAM Challenge's settings A, B, C, and D were 96.7%, 94.4%, 94.0%, and 84.3%. Their recalls were 93.6%, 94.4%, 93.6%, and 77.6%. Their precisions were 100%, 94.4%, 94.4%, and 92.4%. These results were comparable to rest of the data sets in Table 2 , but keep in mind that only 25 mutations were simulated in those regions, and did not necessarily represent the reality. In general, SomaticSeq is not expected to perform too well in low mappability regions in its current implementation, because all the callers it has incorporated depend on short read mapping as a precursor to variant calling.
2.2.1.
Negative predictive values (NPV) . Negative predictive value (NPV) is the fraction of true negative calls over all negative calls. Since the rate of somatic mutation is typically around 1 out of a million, NPV over the whole genome is close to 1 for all sensible somatic mutation callers. However, we calculated our NPV not over the entire genome, but over the union of call sets. This evaluates SomaticSeq's ability to filter out false positives from the call set. Results are shown in Table 16. 2.3. Reduced feature sets. SomaticSeq used up to 72 features to discriminate true somatic mutations from the data sets. All features have some predictive values, but some have much greater predictive values than others. We have already listed the top 18 features in the Method section of the main text, and also tested the algorithm with only the top 5, 10, and 20 features (Table 17 ). The prediction accuracies improve with more features, but diminish after about 20 most valuable features (Fig. 2) . The top 5 features were strand bias odd ratio, normal read depth, tumor mapping quality, MuTect classification, and variant reverse read counts (should be the same weight as forward read counts, but in choosing top 5, only one made the cut). The next 5 top features rounding up the top 10 were variant forward read counts, VarDict classification, VarDict's somatic score, normal mapping quality, and JointSNVMix2 classification. Fig. 3 visualizes the breakdown of true somatic mutations vs. false positives for some features of different importance in the Stage 3 of DREAM Challenge.
The classifier from a trained model is an ensemble of decision trees with different relative weights. The number of decision trees is the number of iterations during training. Decision trees in the beginning are more heavily weighted than decision trees at the end. The decision tree shown in the main manuscript is also represented as Fig. 4. if MuTect, if VarDict, if JointSNVMix2 are classifications by these tools, and hold binary values of 0 or 1. if dbsnp represents membership in dbSNP, and also holds binary values of 0 and 1. VarScan2 Score is the Phred-scaled Fisher's exact test p-value reported by VarScan2. SomaticSeq has in essence reclassified VarScan2's calls in this tree to have a more strict p-value cut off. T MQ is tumor mapping quality which ranges from 0 to 60 for BWA aligned reads.
Some features were turned off in certain cases, e.g., all features related to dbSNP were turned off for in silico titration and SomaticSpike analysis, because most virtual somatic mutations in those two data sets were in dbSNP, but in reality mutation candidates in dbSNP tend to be germline variant false positives. Features related to SomaticSniper and JointSNVMix2 were effectively turned off for INDEL analyses because these two tools do not call INDELs. Indel length was effectively turned off for SNV because it's always zero.
2.4. Reduced size of training sets. Tables 18 and 19 ( Fig. 5 and 6) shows SomaticSeq accuracy as a function of the size of training set. The prediction accuracy improved with increasing size, but reached diminishing return when there were about 200 true positives in the training set. A call set typically has more false positive than true positives, thus we recommend the size of training set should be large enough to include at least 100 true positives. If in rare cases when the number of true positives outnumbers false positives, the size of the training set should include at least 100 false positives instead.
Data Availability
For the DREAM Somatic Mutation Challenge data, GeneTorrent is required to download the BAM files. GeneTorrent is available at UCSC: https://cghub.ucsc.edu/software/downloads.html. The public key for DREAM Challenge is located at http://dream.annailabs.com/dream_public.pem. Specifically, we have used Stage 2 and Stage 3 data from DREAM Challenge in this paper. The URL's of the data for GeneTorrent are:
• Table 3 . Prior probability of somatic mutation is enforced to be 1 in a million in order to get a more realistic performance. VAF N and VAF T stand for variant allele frequencies of the Normal and the Tumor, respectively. VarScan+Filter and Sniper+Filter are subsets of VarScan2 and SomaticSniper output, respectively, with author-recommended false positive filters applied. The trained model for SomaticSeq* is the combined settings of the in silico titration randomly split into half, which has 6 times the data size used during cross validation. The trained model for SomaticSeq** is the DREAM Challenge with settings A and B combined, with dbSNP features discarded. Table 4 . SomaticSpike. Tumor sequencing depth = 10X. Prior probability of somatic mutation is enforced to be 1 in a million in order to get a more realistic performance.
20X
Recall Figure 1 . The average F 1 scores vs. the number of tools. The gain in accuracy with each addition is the greatest when the data are the mostchallenging (i.e., DC3D and N 2.5 T 15 ), and the least when the data are the simplest (i.e., DC3A and N 0 T 50 ). There is also a diminishing return as you add more and more tools. Table 17 . Figure 3 . (a) Mean base quality score in tumor is often the most important feature in the machine learned classifier. Sequencing errors occur more frequently than somatic mutations. Thus, a variant call based on poor base quality is more likely a sequencing error than a true somatic mutation. (b) Number of mismatches reported by VarDict. The vast majority of the true somatic mutations have one mismatch in the read: the variant base itself. (c) Rootmean-square mapping quality (MQ) score of the tumor reads. MQ is a strong predictor, showing that almost all true somatic mutations have MQ above 57. (d) z-score of base quality rank sum between the reference and alternate reads in tumor reads. It is a measure of base quality bias between the reference and alternate reads. This is a weaker predictor than BQ, but also holds value as large-magnitude z-scores are enriched with false positives comparing to z-scores close to 0. All figures here are generated from Stage 3 of DREAM Challenge data. Table 18 . For comparison, the best individual tool's F 1 scores were 0.789 (MuTect), 0.624 (MuTect), 0.607 (SomaticSniper) and 0.296 (VarDict) for DC3A, DC3D, N 0 T 50 , and N 2.5 T 15 , respectively. Table 19 . For comparison, the best individual tool's F 1 scores were 0.707 (VarDict), 0.525 (VarDict), 0.729 (Indelocator), and 0.165 (VarDict) for DC3A, DC3D, N 0 T 50 , and N 2.5 T 15 , respectively. 
